Compare SLNO & WLTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLNO | WLTH |
|---|---|---|
| Founded | 1999 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 2014 | 2025 |
| Metric | SLNO | WLTH |
|---|---|---|
| Price | $42.23 | $9.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $110.90 | $17.13 |
| AVG Volume (30 Days) | 1.6M | ★ 1.6M |
| Earning Date | 02-26-2026 | 01-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.87 |
| Revenue | $98,675,000.00 | ★ $351,537,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $155.86 | N/A |
| P/E Ratio | ★ N/A | $10.92 |
| Revenue Growth | N/A | ★ 42.52 |
| 52 Week Low | $39.43 | $9.45 |
| 52 Week High | $90.32 | $14.88 |
| Indicator | SLNO | WLTH |
|---|---|---|
| Relative Strength Index (RSI) | 36.70 | N/A |
| Support Level | $39.43 | N/A |
| Resistance Level | $50.88 | N/A |
| Average True Range (ATR) | 2.79 | 0.00 |
| MACD | -0.24 | 0.00 |
| Stochastic Oscillator | 26.46 | 0.00 |
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
Wealthfront Corp is a technology company that built a financial solutions platform for digital natives. Its platform is designed to address the needs of the wealth builders within these generations.